Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO). REDHILL BIOPHAR/S ADR (NASDAQ: RDHL) (announced addition of its Talicia, meant to treat H. pylori infection, to Prime Therapeutics NetResults A-Series National Formulary). "As we have designed our COVID-19 vaccine INO-4800 using the same strategy as INO-4700, including the selection of full length Spike protein as the target and the use of intradermal CELLECTRA device, we are hopeful that the ongoing Phase 1 clinical trial with INO-4800 would generate similar clinical immune responses and safety data as we have just reported for INO-4700," CEO Dr. Joseph Kim said in a statement. Supernus Pharmaceuticals Inc (NASDAQ: SUPN) announced a definitive agreement under which it will acquire the CNS portfolio of US WorldMeds, a privately held biopharmaceutical company, for an upfront payment of $300 million, plus cash milestone payments of up to $230 million.
1 other references
The Daily Biotech Pulse: Inovio's MERS Vaccine Data, Fast Track Designation For Erytech, FDA Approves Higher Dose Of Merck's KeytrudaPublished on 29/04/2020 12:40 by: finance.yahoo.com
Latest Stories From Referenced Companies
COVID-19 Impact Analysis: Wireless Patient Monitor System Market to Access Huge Growth by 2020-2027 Focusing on Leading Players – Boston Scientific Corporation, GE Healthcare, Johnson and Johnson – Jewish Market Reports
Jul 15, 2020
Jul 15, 2020